Keywords: royalty, pharma, buys, stake, remicade, ip, usa-based

Royalty Pharma buys stake in Remicade IP

Article | 14 May 2007

Print This

USA-based Royalty Pharma, a specialist in the acquisition of revenue producing intellectual property, says that New York University has sold ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in